potassium-oxonate and acacetin

potassium-oxonate has been researched along with acacetin* in 1 studies

Other Studies

1 other study(ies) available for potassium-oxonate and acacetin

ArticleYear
Hypouricemic effects of acacetin and 4,5-o-dicaffeoylquinic acid methyl ester on serum uric acid levels in potassium oxonate-pretreated rats.
    Biological & pharmaceutical bulletin, 2005, Volume: 28, Issue:12

    The effects of acacetin (1) and 4,5-O-dicaffeoylquinic acid methyl ester (2), compounds contained in the flowers of Chrysanthemum sinense SABINE, on the serum uric acid level were investigated using the rats pretreated with the uricase inhibitor potassium oxonate as an animal model for hyperuricemia. When administered per orally at doses of 20 and 50 mg/kg, 1 reduced the serum uric acid level by 49.9 and 63.9%, respectively and 2 reduced the level by 31.2 and 44.4%, respectively. On the other hand, when the same doses were given intraperitoneally, both of compounds also exhibited a dose-dependent and more marked reduction of the serum uric acid level (% reduction at 20 and 50 mg/kg were 63.0 and 95.1% in 1, respectively and 66.9 and 86.5% in 2, respectively). Furthermore, the compounds 1 and 2 inhibited the rat liver xanthine oxidase activity with IC(50) values of 2.22 muM and 5.27 muM, respectively. These results demonstrated the hypouricemic action of 1 and 2, which may be attributable to their xanthine oxidase inhibitory activity.

    Topics: Administration, Oral; Allopurinol; Animals; Chrysanthemum; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Esters; Flavones; Hyperuricemia; Inhibitory Concentration 50; Injections, Intraperitoneal; Liver; Male; Oxonic Acid; Quinic Acid; Rats; Rats, Sprague-Dawley; Uric Acid; Xanthine Oxidase

2005